Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings		$ 9,710	$ 8,592	$ 7,728
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization		998	981	964
Deferred income tax (benefit) provision		(17)	(143)	(141)
Asset impairment and exit costs, net of cash paid (Note 19)		(22)	(14)	371
Cash effects of changes, net of the effects from acquired companies:
Receivables, net		(198)	26	(331)
Inventories		549	(165)	(548)
Accounts payable		653	406	451
Accrued liabilities and other current assets		623	121	1,108
Income taxes		(260)	(260)	75
Pension plan contributions		(269)	(102)	(200)
Other	[1]	200	370	613
Net cash provided by operating activities		11,967	9,812	10,090
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures		(748)	(602)	(852)
Acquisitions, net of acquired cash (Note 6)		(2,111)	0	0
Equity investments		(34)	(47)	(31)
Deconsolidation of RBH (Note 20)	[2]	0	0	(1,346)
Net investment hedges		466	(551)	386
Other		69	46	32
Net cash used in investing activities		(2,358)	(1,154)	(1,811)
Short-term borrowing activity by original maturity:
Net issuances (repayments) - maturities of 90 days or less		0	(70)	(364)
Issuances - maturities longer than 90 days		0	45	989
Repayments - maturities longer than 90 days		0	(45)	(989)
Long-term debt proceeds		0	3,713	3,819
Long-term debt repaid		(3,042)	(3,999)	(3,998)
Repurchases of common stock		(775)	0	0
Dividends paid		(7,580)	(7,364)	(7,161)
Payments to noncontrolling interests and Other		(580)	(776)	(357)
Net cash used in financing activities		(11,977)	(8,496)	(8,061)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(417)	258	27
Cash, cash equivalents and restricted cash:
Increase (Decrease)	[3]	(2,785)	420	245
Balance at beginning of year	[3]	7,285	6,865	6,620
Balance at end of year	[3]	4,500	7,285	6,865
Cash Paid:
Interest		716	728	800
Income taxes		$ 2,936	$ 2,785	$ 2,430

[1] Includes the Loss on Deconsolidation of RBH ($239 million) and the Canadian tobacco litigation-related charge ($194 million) that were included in marketing, administration and research costs in the consolidated statements of earnings for the year ended December 31, 2019. For further details on these charges, see Note 20. Deconsolidation of RBH.

[2] Includes deconsolidation of RBH cash and cash equivalents of $1,323 million and restricted cash of $23 million.

[3] The amounts for cash, cash equivalents and restricted cash shown above include restricted cash of $4 million, $5 million and $4 million as of December 31, 2021, 2020 and 2019, respectively, which were included in other current assets in the consolidated balance sheets.